Evidence map›Paper›PMID 41954507›Full record

ArticleIUCrJ2026

Structural insights into MltB from Acinetobacter baumannii: a conserved catalytic tunnel with unique domain arrangement.

Hyunseok Jang, Chang Min Kim, Chang Sup Lee, Hyun Ho Park

Abstract read
In one paragraph

Article in IUCrJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hyunseok JangCollege of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea.ORCID 0000-0003-4205-4448
Chang Min KimDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Chang Sup LeeCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, Republic of Korea.
Hyun Ho ParkCollege of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea.ORCID 0000-0001-9928-0847

Funding

National Research Foundation of Korea RS-2025-02316334National Research Foundation of Korea RS-2026-25470081
6 · The paper itself

Abstract

Lytic transglycosylases (LTs) play a central role in bacterial cell wall remodeling by cleaving the β-1,4-glycosidic bond in peptidoglycan via a non-hydrolytic mechanism, producing 1,6-anhydroMurNAc termini crucial for recycling and signaling. Among LTs, membrane-bound lytic transglycosylase B (MltB) contributes to peptidoglycan turnover, antibiotic resistance and protein-protein interactions. Despite its importance, the structural basis of MltB function in Acinetobacter baumannii, a multidrug-resistant pathogen, remains unclear. Here, we report the crystal structure of abMltB at 1.79 Å resolution. abMltB adopts a monomeric structure comprising three domains: an N-terminal domain (NTD), a catalytic domain (CD) and a C-terminal domain (CTD). The NTD connects to the CD via a flexible loop that partially occludes the active site, forming a tunnel-like cavity. Comparative analysis with homologous enzymes such as SltB1 and Slt35 reveals conserved catalytic residues, including Glu129 and key aromatic residues, while the CTD in abMltB adopts a distinct orientation. Notably, although calcium ions stabilize related enzymes, no metal binding was observed in abMltB. These findings highlight conserved mechanistic features and unique structural adaptations of abMltB, offering insight into its functional role in A. baumannii and potential as a novel antimicrobial target.

Indexed as

Acinetobacter baumanniiBacterial ProteinsGlycosyltransferasesCatalytic DomainCrystallography, X-RayModels, MolecularPeptidoglycanBacterial ProteinsGlycosyltransferasesPeptidoglycanAcinetobacter baumanniiantimicrobialslytic transglycosylasesMltB

Identifiers

PMID41954507
PMCPMC13134497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.